Clinical Trial Update: Rucaparib in Nonmetastatic prOstAte With BRCAness [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for rucaparib in nonmetastatic prostate cancer with BRCAness has been terminated; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: University of Utah | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-03-13